Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer
6
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
ipo
6
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
6
×
san diego blog main
6
×
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
6
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boston top stories
fda
deals
eli lilly
novartis
takeda pharmaceutical
allergan
alzheimer's disease
biogen
cancer immunotherapy
clinical trials
What
bio
roundup
pharmaceutical
black
companies
covid
diamond’s
drugs
ipo
life
medicines
new
science
typically
acquisitions
activity
alzheimer’s
announced
appetite
approvals
bails
biogen
brand
bread
bridgebio
butter
buyout
cancer
capital
car
cash
ceo
clamped
collabs
continue
daniel
deal
debut
delays
develop
Language
unset
Current search:
cancer
×
startups
×
" raleigh-durham top stories "
×
ipo
×
" san diego blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More